With Cannabis 2.0 fully underway, licensed processors now have the opportunity to begin producing additional classes of cannabis, and to develop new and exciting products to add to their portfolios. […] Read More >>
The preparation and submission of a federal cannabis licence application can be extremely gruelling and quite challenging. At first glance, a licence application may seem straightforward and easy to compile […] Read More >>
Clinical research involving cannabis has had a challenging history; until very recently (and arguably still) it remains an area of clinical research characterized by historically heavy regulation and seemingly endless […] Read More >>
The Canadian Health Food Association (CHFA) and the Canadian Hemp Trade Association (CHTA) released a white paper on the “Smart Regulation of CBD” calling for the federal government to remove […] Read More >>
Beginning in October 2019, cannabis processors will be able to start producing new classes of cannabis products. Health Canada is now accepting license amendments to allow for the production of […] Read More >>
Canada Cannabidiol (CBD) is a naturally-occurring phytocannabinoid in the Cannabis sativa L. plant and is responsible for many of the therapeutic properties associated with cannabis. It is important to know […] Read More >>
Effective immediately, Health Canada will require new applicants for cultivation, processing or sale for medical purposes licences to have a fully built site that meets all the requirements of the […] Read More >>
Two weeks ago, Canada finally legalized cannabis for retail sale and we saw products packaged in very generic-looking containers. Each container featured a stop sign-style THC warning and a bright […] Read More >>
Health Canada recently revised the cosmetic ingredient hotlist, a science-based document used to communicate known safety concerns associated with cosmetic ingredients. This revision resulted in “cannabis, as defined in subsection […] Read More >>
Every day, we take for granted the medical treatments offered by our physicians for illnesses like hypertension and epilepsy. If medical professionals and the pharmaceutical industry did not invest in […] Read More >>
Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or email@example.com. Update (June 28, 2018): CBD as […] Read More >>
On April 11, 2018, Ontario announced the first four locations for cannabis retail stores, provincially run by the LCBO and the Ontario Cannabis Store (OCS), while other provinces had made […] Read More >>
dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.
Stay abreast of regulatory updates, news, events, offers and more
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.